Research ExplorerPublicationsComparable results in patients with acute lymphoblastic leuk...

Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation.

Standard

Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation. / Dahlke, Joachim; Kröger, Nicolaus; Zabelina, Tatjana; Ayuketang Ayuk, Francis; Wolschke, Christine; Renges, Helmut-Hans; Krüger, William; Kruell, A; Hinke, A; Erttmann, Rudolf; Kabisch, Hartmut; Zander, Axel R.

In: BONE MARROW TRANSPL, Vol. 37, No. 2, 2, 2006, p. 155-163.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Dahlke, J, Kröger, N, Zabelina, T, Ayuketang Ayuk, F, Wolschke, C, Renges, H-H, Krüger, W, Kruell, A, Hinke, A, Erttmann, R, Kabisch, H & Zander, AR 2006, 'Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation.', BONE MARROW TRANSPL, vol. 37, no. 2, 2, pp. 155-163. <http://www.ncbi.nlm.nih.gov/pubmed/16284608?dopt=Citation>

APA

Dahlke, J., Kröger, N., Zabelina, T., Ayuketang Ayuk, F., Wolschke, C., Renges, H-H., Krüger, W., Kruell, A., Hinke, A., Erttmann, R., Kabisch, H., & Zander, A. R. (2006). Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation. BONE MARROW TRANSPL, 37(2), 155-163. [2]. http://www.ncbi.nlm.nih.gov/pubmed/16284608?dopt=Citation

Vancouver

Dahlke J, Kröger N, Zabelina T, Ayuketang Ayuk F, Wolschke C, Renges H-H et al. Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation. BONE MARROW TRANSPL. 2006;37(2):155-163. 2.

Bibtex

@article{95f1677f78df447ba986b05a56006f90,
title = "Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation.",
abstract = "We report the results of 84 patients with ALL after related (n = 46) or unrelated (n = 38) allogeneic SCT. Mean recipient age was 23 years (range: 1-60) and median follow-up was 18 months (range: 1-133). Forty-three patients were transplanted in CR1; 25 in CR2 or CR3; four were primary refractory; four in PR; eight in relapse. The conditioning regimen consisted of TBI/VP16/CY (n = 76), TBI/VP16 (n = 2), TBI/CY (n = 2), Bu/VP16/CY (n = 4). The OS at 3 years was 45% (44% unrelated, 46% related). Univariate analysis showed a significantly better OS for patients",
author = "Joachim Dahlke and Nicolaus Kr{\"o}ger and Tatjana Zabelina and {Ayuketang Ayuk}, Francis and Christine Wolschke and Helmut-Hans Renges and William Kr{\"u}ger and A Kruell and A Hinke and Rudolf Erttmann and Hartmut Kabisch and Zander, {Axel R.}",
year = "2006",
language = "Deutsch",
volume = "37",
pages = "155--163",
journal = "BONE MARROW TRANSPL",
issn = "0268-3369",
publisher = "NATURE PUBLISHING GROUP",
number = "2",

}

RIS

TY - JOUR

T1 - Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation.

AU - Dahlke, Joachim

AU - Kröger, Nicolaus

AU - Zabelina, Tatjana

AU - Ayuketang Ayuk, Francis

AU - Wolschke, Christine

AU - Renges, Helmut-Hans

AU - Krüger, William

AU - Kruell, A

AU - Hinke, A

AU - Erttmann, Rudolf

AU - Kabisch, Hartmut

AU - Zander, Axel R.

PY - 2006

Y1 - 2006

N2 - We report the results of 84 patients with ALL after related (n = 46) or unrelated (n = 38) allogeneic SCT. Mean recipient age was 23 years (range: 1-60) and median follow-up was 18 months (range: 1-133). Forty-three patients were transplanted in CR1; 25 in CR2 or CR3; four were primary refractory; four in PR; eight in relapse. The conditioning regimen consisted of TBI/VP16/CY (n = 76), TBI/VP16 (n = 2), TBI/CY (n = 2), Bu/VP16/CY (n = 4). The OS at 3 years was 45% (44% unrelated, 46% related). Univariate analysis showed a significantly better OS for patients

AB - We report the results of 84 patients with ALL after related (n = 46) or unrelated (n = 38) allogeneic SCT. Mean recipient age was 23 years (range: 1-60) and median follow-up was 18 months (range: 1-133). Forty-three patients were transplanted in CR1; 25 in CR2 or CR3; four were primary refractory; four in PR; eight in relapse. The conditioning regimen consisted of TBI/VP16/CY (n = 76), TBI/VP16 (n = 2), TBI/CY (n = 2), Bu/VP16/CY (n = 4). The OS at 3 years was 45% (44% unrelated, 46% related). Univariate analysis showed a significantly better OS for patients

M3 - SCORING: Zeitschriftenaufsatz

VL - 37

SP - 155

EP - 163

JO - BONE MARROW TRANSPL

JF - BONE MARROW TRANSPL

SN - 0268-3369

IS - 2

M1 - 2

ER -